Anna Gidari

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Systematic Review

Coronavirus Disease

Intensive Care Unit

Top Venues

Infectious disease reports

This page only lists publications with an associated author ORCID identifier.

Publications

Carlo Pallotto, Andrea Tommasi, Elisabetta Svizzeretto, Giovanni Genga, Giulia Gamboni, Anna Gidari, Daniela Francisci
Bloodstream Infections Due to Wild-Type Pseudomonas aeruginosa : Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes. Infectious disease reports 16 (5) (2024)
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Svizzeretto, Andrea Tommasi, Carlo Pallotto, Elisabetta Schiaroli, Daniela Francisci
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? Viruses 16 (3) (2024)
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Svizzeretto, Andrea Tommasi, Carlo Pallotto, Elisabetta Schiaroli, Daniela Francisci
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? Viruses 16 (3) (2024)
Anna Gidari, Carlo Pallotto, Daniela Francisci
Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series. Infection (2024)
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Svizzeretto, Andrea Tommasi, Carlo Pallotto, Elisabetta Schiaroli, Daniela Francisci
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? Viruses 16 (3) (2024)
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Svizzeretto, Andrea Tommasi, Carlo Pallotto, Elisabetta Schiaroli, Daniela Francisci
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? Viruses 16 (3) (2024)
Alessandro Paciaroni, Valeria Libera, Francesca Ripanti, Andrea Orecchini, Caterina Petrillo, Daniela Francisci, Elisabetta Schiaroli, Samuele Sabbatini, Anna Gidari, Elisa Bianconi, Antonio Macchiarulo, Rohanah Hussain, Lucia Silvestrini, Paolo Moretti, Norhan Belhaj, Matteo Vercelli, Yessica Roque, Paolo Mariani, Lucia Comez, Francesco Spinozzi
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir. International journal of molecular sciences 24 (7) (2023)
Anna Gidari, Sara Benedetti, Sara Tordi, Anastasia Zoffoli, Debora Altobelli, Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Daniela Francisci
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH). Infectious disease reports 15 (6) (2023)
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Lavinia Maria Saraca, Luca Capogrossi, Maria Bruna Pasticci, Daniela Francisci
Synergistic Activity of Remdesivir-Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report. Viruses 15 (7) (2023)
Anna Gidari, Sara Benedetti, Sara Tordi, Anastasia Zoffoli, Debora Altobelli, Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Daniela Francisci
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH). Infectious disease reports 15 (6) (2023)
Anna Gidari, Sara Benedetti, Sara Tordi, Anastasia Zoffoli, Debora Altobelli, Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Daniela Francisci
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH). Infectious disease reports 15 (6) (2023)
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Lucia Comez, Valeria Libera, Antonio Macchiarulo, Alessandro Paciaroni, Ilaria Vicenti, Maurizio Zazzi, Daniela Francisci
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro. Microorganisms 10 (7) (2022)
Anna Gidari, Samuele Sabbatini, Carlo Pallotto, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Schiaroli, Daniela Francisci
Nelfinavir: An Old Ally in the COVID-19 Fight? Microorganisms 10 (12) (2022)
Lia Fiaschi, Filippo Dragoni, Elisabetta Schiaroli, Annalisa Bergna, Barbara Rossetti, Federica Giammarino, Camilla Biba, Anna Gidari, Alessia Lai, Cesira Nencioni, Daniela Francisci, Maurizio Zazzi, Ilaria Vicenti
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2. Viruses 14 (7) (2022)
Anna Gidari, Samuele Sabbatini, Carlo Pallotto, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Schiaroli, Daniela Francisci
Nelfinavir: An Old Ally in the COVID-19 Fight? Microorganisms 10 (12) (2022)
Anna Gidari, Samuele Sabbatini, Carlo Pallotto, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Schiaroli, Daniela Francisci
Nelfinavir: An Old Ally in the COVID-19 Fight? Microorganisms 10 (12) (2022)
Anna Gidari, Samuele Sabbatini, Carlo Pallotto, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Schiaroli, Daniela Francisci
Nelfinavir: An Old Ally in the COVID-19 Fight? Microorganisms 10 (12) (2022)
Anna Gidari, Samuele Sabbatini, Carlo Pallotto, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Elisabetta Schiaroli, Daniela Francisci
Nelfinavir: An Old Ally in the COVID-19 Fight? Microorganisms 10 (12) (2022)
Giuseppe Vittorio De Socio, Anna Gidari, Francesco Sicari, Michele Palumbo, Daniela Francisci
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study. Infection 49 (5) (2021)
Vanessa Bianconi, Massimo Raffaele Mannarino, Filippo Figorilli, Elisabetta Schiaroli, Elena Cosentini, Giuseppe Batori, Ettore Marini, Amir Hossein Sahebkar, Francesco Grignani, Anna Gidari, Daniela Francisci, Matteo Pirro
Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19. Journal of clinical medicine 10 (22) (2021)
Anna Gidari, Marco Nofri, Luca Saccarelli, Sabrina Bastianelli, Samuele Sabbatini, Silvia Bozza, Barbara Camilloni, Igino Fusco-Moffa, Claudia Monari, Michael P Casaer, Antonella Mencacci, Daniela Francisci
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 40 (1) (2020)
Anna Gidari, Giuseppe Vittorio De Socio, Samuele Sabbatini, Daniela Francisci
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection. Infectious diseases (London, England) 52 (10) (2020)